Mineralocorticoid receptor antagonists for chronic heart failure: a meta-analysis focusing on the number needed to treat
出版年份 2023 全文链接
标题
Mineralocorticoid receptor antagonists for chronic heart failure: a meta-analysis focusing on the number needed to treat
作者
关键词
-
出版物
Frontiers in Cardiovascular Medicine
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-11-07
DOI
10.3389/fcvm.2023.1236008
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cardiovascular-renal protective effect and molecular mechanism of finerenone in type 2 diabetic mellitus
- (2023) Ruolin Lv et al. Frontiers in Endocrinology
- Effects of Mineralocorticoid Receptor Antagonists in Early-Stage Heart Failure With Preserved Ejection Fraction
- (2023) Kazuki Kagami et al. CJC Open
- Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases
- (2022) Jonatan Barrera-Chimal et al. Annual Review of Physiology
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
- (2022) Paul A. Heidenreich et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease
- (2022) Edgar Lerma et al. POSTGRADUATE MEDICINE
- Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
- (2022) Arjun K Pandey et al. EUROPEAN HEART JOURNAL
- Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure
- (2022) Josefin Henrysson et al. ESC Heart Failure
- Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population
- (2022) Anna Jonsson Holmdahl et al. Open Heart
- Clinical Characteristics and Outcomes of Hospitalized Patients With Heart Failure From the Large-Scale Japanese Registry Of Acute Decompensated Heart Failure (JROADHF)
- (2021) Tomomi Ide et al. CIRCULATION JOURNAL
- Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care
- (2021) Marco Trevisan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Aldosterone Blockade in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis
- (2021) Qiao Chen et al. Cardiovascular Therapeutics
- Epidemiology of heart failure
- (2020) Amy Groenewegen et al. EUROPEAN JOURNAL OF HEART FAILURE
- The number needed to treat in pairwise and network meta-analysis and its graphical representation
- (2019) Areti Angeliki Veroniki et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Mineralocorticoid Antagonism and Diabetic Kidney Disease
- (2019) Yuliya Lytvyn et al. Current Diabetes Reports
- Cardiovascular Protection with Anti-hyperglycemic Agents
- (2019) Prakash Deedwania et al. American Journal of Cardiovascular Drugs
- Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis
- (2019) Qing Zeng et al. Drug Design Development and Therapy
- Double-Blind, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Eplerenone in Japanese Patients With Chronic Heart Failure (J-EMPHASIS-HF)
- (2018) Hiroyuki Tsutsui et al. CIRCULATION JOURNAL
- Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists
- (2018) Marco Trevisan et al. EUROPEAN JOURNAL OF HEART FAILURE
- 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
- (2017) Peter Kolkhof et al. JOURNAL OF ENDOCRINOLOGY
- Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis
- (2016) Nicolas M. Berbenetz et al. BMC Cardiovascular Disorders
- A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
- (2016) Gerasimos Filippatos et al. EUROPEAN HEART JOURNAL
- Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons
- (2016) Diogo Mendes et al. Expert Opinion On Drug Safety
- Nonsteroidal antagonists of the mineralocorticoid receptor
- (2015) Peter Kolkhof et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone
- (2015) Diogo Mendes et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms
- (2013) Enrico Vizzardi et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
- (2013) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed
- (2013) L. Citrome et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
- (2013) Frank Edelmann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice
- (2012) F. Zannad et al. EUROPEAN HEART JOURNAL
- Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
- (2012) David Preiss et al. EUROPEAN JOURNAL OF HEART FAILURE
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Relative vs. absolute measures of benefit and risk: whatâs the difference?
- (2009) L. Citrome ACTA PSYCHIATRICA SCANDINAVICA
- Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results
- (2009) Alessandro Boccanelli et al. EUROPEAN JOURNAL OF HEART FAILURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now